Misdiagnosis of narcolepsy caused by a false-positive orexin-A/hypocretin-1 enzyme immune assay.


Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
01 08 2022
Historique:
pubmed: 29 4 2022
medline: 3 8 2022
entrez: 28 4 2022
Statut: ppublish

Résumé

The diagnosis of narcolepsy is based on clinical history, sleep studies, and, in some cases, cerebrospinal fluid orexin-A/hypocretin-1 measurement. The gold standard for orexin measurement is the radioimmunoassay but other commercial kits are also available, such as the enzyme immune assay (EIA). The specificity of orexin EIA in humans is unknown. We report four cases where orexin levels were measured by EIA and resulted in false positives and the misdiagnosis of narcolepsy. Therefore, orexin EIA measurement should be strongly discouraged in a clinical setting. Sarkanen T, Sved G, Juujärvi M, Alakuijala A, Partinen M. Misdiagnosis of narcolepsy caused by a false-positive orexin-A/hypocretin-1 enzyme immune assay.

Identifiants

pubmed: 35481446
pii: jcsm.10014
doi: 10.5664/jcsm.10014
pmc: PMC9340599
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Neuropeptides 0
Orexins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2075-2078

Informations de copyright

© 2022 American Academy of Sleep Medicine.

Références

Neurology. 2001 Jun 26;56(12):1749-51
pubmed: 11425946
PLoS One. 2016 Mar 23;11(3):e0151288
pubmed: 27008404
Sleep. 1997 Aug;20(8):620-9
pubmed: 9351129
Clin Biochem. 2021 Apr;90:34-39
pubmed: 33539807
Sci Rep. 2016 May 11;6:25162
pubmed: 27165941
Neurosci Lett. 2002 Jan 25;318(2):61-4
pubmed: 11796186
Anal Chem. 2019 Jul 16;91(14):9323-9329
pubmed: 31260261
Biol Psychiatry. 2003 Jul 15;54(2):96-104
pubmed: 12873798
Sleep Med Rev. 2020 Aug;52:101306
pubmed: 32311642
Brain. 2006 Jun;129(Pt 6):1609-23
pubmed: 16597649
Vaccine. 2013 Jan 30;31(6):994-1007
pubmed: 23246545
Peptides. 2002 Dec;23(12):2203-11
pubmed: 12535700

Auteurs

Tomi Sarkanen (T)

Department of Neurology, Tampere University Hospital, Tampere, Finland.
Department of Neurology, Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.

Gabriele Sved (G)

Helsinki Sleep Clinic, Terveystalo Biobank and Clinical Research, Helsinki, Finland.

Maria Juujärvi (M)

Department of Clinical Chemistry, Fimlab Laboratories Ltd, Tampere, Finland.

Anniina Alakuijala (A)

Department of Clinical Neurophysiology, HUS Medical Imaging Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Markku Partinen (M)

Helsinki Sleep Clinic, Terveystalo Biobank and Clinical Research, Helsinki, Finland.
Department of Clinical Neurosciences, Clinicum, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH